Key Stats for AVTR Stock
- Price Change for AVTR stock: -13.62%
- AVTR Share Price as of Feb. 11: $9.64
- 52-Week High: $18.36
- AVTR Stock Price Target: $12.04
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Avantor (AVTR) shares have continued to trend lower as investors reacted to weak demand across biopharma and academic research markets.
The company reported softer revenue trends, and growth slowed as customers reduced spending and worked through excess inventories.
Margins also came under pressure, as lower volumes weighed on operating leverage and profitability.
While management reiterated long-term demand drivers, near-term conditions remained challenging, which kept pressure on the stock.
See analysts’ growth forecasts and price targets for AVTR stock (It’s free!) >>>
Analysts currently have a mean price target of $12, which sits above the stock’s current trading level.
The median price target stands at $12, while the high target reaches $19, reflecting expectations for demand normalization over time.
On the downside, the low target is $9, highlighting continued downside risk if end-market weakness persists. Street Targets data shows a target-to-price ratio of 125%, indicating analysts still see potential recovery from depressed levels.
What the Market Is Telling Us About AVTR Stock
Avantor’s fundamentals reflect a difficult operating environment, but also show signs of stabilization. LTM revenue totaled approximately $6.4 billion, but growth remained muted due to customer inventory adjustments.
Gross margins declined to around 33%, while operating margins compressed as volumes softened. Free cash flow weakened, but the company continues to focus on cost controls and working capital efficiency.
Avantor’s balance sheet remains manageable, although leverage remains elevated, which limits near-term flexibility. Key headwinds include biopharma funding pressure and slower academic spending, while tailwinds include long-term growth in life sciences research.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does AVTR Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
